ThermoGenesis Holdings, Inc. short interest in 2018
In 2018, ThermoGenesis Holdings, Inc.'s disclosed short interest ran from 3.02% of shares outstanding on 12 Jan 2018 to 2.23% on 31 Dec 2018, a change of -0.79 percentage points. The year's high was 6.89% on 15 May 2018 and its low 1.57% on 15 Aug 2018, averaging 3.19% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.71 days on 28 Feb 2018. Full history: ThermoGenesis Holdings, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2018 in figures
- Start of year
- 3.02% (12 Jan 2018)
- End of year
- 2.23% (31 Dec 2018)
- Change
- -0.79 pp
- High
- 6.89% (15 May 2018)
- Low
- 1.57% (15 Aug 2018)
- Average
- 3.19%
- Highest days to cover
- 15.71 (28 Feb 2018)
- SEC filings marked
- 7
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 3.02% | 1.15 | |
| 31 Jan 2018 | 2.76% | 6.53 | |
| 15 Feb 2018 | 3.31% | 9.28 | |
| 28 Feb 2018 | 3.18% | 15.71 | |
| 15 Mar 2018 | 3.05% | 5.43 | |
| 29 Mar 2018 | 2.84% | 3.85 | results (8-K) |
| 13 Apr 2018 | 3.22% | 1.65 | |
| 30 Apr 2018 | 5.09% | 4.70 | |
| 15 May 2018 | 6.89% | 2.25 | 10-Q filed, results (8-K) |
| 31 Jul 2018 | 3.02% | 1.13 | |
| 15 Aug 2018 | 1.57% | 1.16 | results (8-K), 10-Q filed |
| 31 Aug 2018 | 1.70% | 1.00 | |
| 14 Sep 2018 | 3.32% | 1.41 | |
| 28 Sep 2018 | 2.89% | 2.25 | |
| 15 Oct 2018 | 3.49% | 1.64 | |
| 31 Oct 2018 | 4.10% | 3.47 | |
| 15 Nov 2018 | 2.99% | 2.45 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 2.71% | 1.00 | |
| 14 Dec 2018 | 2.47% | 4.65 | |
| 31 Dec 2018 | 2.23% | 2.74 |
See also: ThermoGenesis Holdings, Inc.'s full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.